Alzheimer's Disease

Showing NaN - NaN of 87

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alzheimer's Disease, Behavioral Variant Frontotemporal Dementia Trial in Worldwide (LMTM)

Terminated
  • Alzheimer's Disease
  • Behavioral Variant Frontotemporal Dementia
  • Phoenix, Arizona
  • +134 more
May 15, 2020

Alzheimer's Disease, Dementia With Lewy Bodies, Parkinson's Disease Dementia Trial in United States (RVT-101 35 mg, Placebo)

Completed
  • Alzheimer's Disease
  • +2 more
  • RVT-101 35 mg
  • Placebo
  • Phoenix, Arizona
  • +10 more
Apr 17, 2020

Alzheimer's Disease Trial in Worldwide (RVT-101 35 mg tablets)

Terminated
  • Alzheimer's Disease
  • RVT-101 35 mg tablets
  • Phoenix, Arizona
  • +168 more
Apr 14, 2020

Alzheimer's Disease Trial in United States (Piromelatine, Placebo)

Completed
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +55 more
Feb 25, 2020

Alzheimer's Disease Trial in Worldwide (Crenezumab)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +85 more
Feb 18, 2020

Alzheimer's Disease Trial in United States ([18F]GTP1)

Completed
  • Alzheimer's Disease
  • New Haven, Connecticut
  • +15 more
Dec 19, 2019

Alzheimer's Disease Trial in Worldwide (Lanabecestat, Placebo)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +261 more
Nov 19, 2019

Alzheimer's Disease Trial in United States (BPN14770, Placebo)

Unknown status
  • Alzheimer's Disease
  • Gilbert, Arizona
  • +40 more
Oct 30, 2019

Alzheimer's Disease Trial in Worldwide (ELND005, Placebo)

Completed
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +69 more
Oct 17, 2019

Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +192 more
Sep 25, 2019

Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +197 more
Sep 25, 2019

Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +146 more
Sep 25, 2019

Alzheimer's Disease Trial in Spain, United States (Albumin 5%, Albumin 20%, Immunoglobulin)

Completed
  • Alzheimer's Disease
  • Albumin 5%
  • +2 more
  • Sacramento, California
  • +39 more
Jul 10, 2019

Alzheimer's Disease Trial in United States (T-817MA-H, T-817MA-L, Placebo)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +49 more
Feb 12, 2019

Alzheimer's Disease Trial in Worldwide (RVT-101, Placebo)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +196 more
Nov 8, 2018

Alzheimer's Disease Trial in Worldwide (Idalopirdine 60 mg)

Completed
  • Alzheimer's Disease
  • Idalopirdine 60 mg
  • Birmingham, Alabama
  • +257 more
Aug 9, 2018

Alzheimer's Disease Trial in Delray Beach, Miami, Charlotte (T3D-959)

Completed
  • Alzheimer's Disease
  • Delray Beach, Florida
  • +2 more
Jul 26, 2018

Alzheimer's Disease Trial in United States (Bryostatin 1, Placebo)

Completed
  • Alzheimer's Disease
  • Bryostatin 1
  • Placebo
  • Phoenix, Arizona
  • +28 more
Jun 6, 2018

Alzheimer's Disease Trial in Worldwide (TRx0237 150 mg/day, TRx0237 250 mg/day, Placebo)

Completed
  • Alzheimer's Disease
  • TRx0237 150 mg/day
  • +2 more
  • Phoenix, Arizona
  • +120 more
Mar 12, 2018

Alzheimer's Disease Trial in Worldwide (Placebo, Idalopirdine)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +161 more
Jan 23, 2018

Alzheimer's Disease Trial in Worldwide (Placebo, Idalopirdine)

Completed
  • Alzheimer's Disease
  • Mesa, Arizona
  • +106 more
Jan 12, 2018

Alzheimer's Disease Trial in Worldwide (Rosiglitazone Extended Release 2mg, Rosiglitazone Extended Release 8mg, Placebo)

Completed
  • Alzheimer's Disease
  • Rosiglitazone Extended Release 2mg
  • +3 more
  • Litchfield Park, Arizona
  • +248 more
Oct 23, 2017

Alzheimer's Disease, Dementia, Alzheimer Type Trial in Worldwide (rivastigmine transdermal patch)

Completed
  • Alzheimer's Disease
  • Dementia, Alzheimer Type
  • rivastigmine transdermal patch
  • Orange, California
  • +74 more
Oct 12, 2017

Alzheimer's Disease Trial in Worldwide (CNP520, Placebo)

Completed
  • Alzheimer's Disease
  • Glendale, California
  • +10 more
Aug 7, 2017

Alzheimer's Disease Trial in Worldwide (MABT5102A, )

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +91 more
Jul 10, 2017